Enrique Carrazana

2015

In 2015, Enrique Carrazana earned a total compensation of $1.5M as Chief Medical Officer at Acorda Therapeutics, a 8% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$235,000
Option Awards$534,853
Salary$464,466
Stock Awards$209,865
Other$79,390
Total$1,523,574

Carrazana received $534.9K in option awards, accounting for 35% of the total pay in 2015.

Carrazana also received $235K in non-equity incentive plan, $464.5K in salary, $209.9K in stock awards and $79.4K in other compensation.

Rankings

In 2015, Enrique Carrazana's compensation ranked 5,897th out of 13,638 executives tracked by ExecPay. In other words, Carrazana earned more than 56.8% of executives.

ClassificationRankingPercentile
All
5,897
out of 13,638
57th
Division
Manufacturing
2,200
out of 5,190
58th
Major group
Chemicals And Allied Products
793
out of 1,854
57th
Industry group
Drugs
633
out of 1,528
59th
Industry
Biological Products, Except Diagnostic Substances
108
out of 254
58th
Source: SEC filing on April 29, 2016.

Carrazana's colleagues

We found six more compensation records of executives who worked with Enrique Carrazana at Acorda Therapeutics in 2015.

2015

Ron Cohen

Acorda Therapeutics

Chief Executive Officer

2015

Jane Wasman

Acorda Therapeutics

General Counsel

2015

Michael Rogers

Acorda Therapeutics

Chief Financial Officer

2015

Lauren Sabella

Acorda Therapeutics

Chief Commercial Officer

2015

David Lawrence

Acorda Therapeutics

Chief, Business Operations and Principal Accounting Officer

2015

Andrew Hindman

Acorda Therapeutics

Chief Business Development Officer

You may also like